New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- China uses seawater for equipment cooling
- Xinjiang's foreign trade grows 40 percent annually since 2021
- Qinghai rescue operation saves 251 trapped hikers after one death
- Vibrant China during holiday: Strong consumption vitality
- Northern Shaanxi's soul cut in paper
- Vision of dancing beyond the desert with dreams pays off
